KEY FEATURES
| Full Name | Granulocyte-Macrophage Colony Stimulating Factor |
|---|---|
| Synonym | GMCSF;CSF2; |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 15.63-1000pg/mL |
| Sensitivity | 9.38pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse GM-CSF in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse GM-CSF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse GM-CSF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse GM-CSF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse GM-CSF. You can calculate the concentration of Mouse GM-CSF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse G-CSF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 51.86 | 139.94 | 496.55 | 52.68 | 142.98 | 484.43 |
| Standard deviation | 3.15 | 5.95 | 17.88 | 3.52 | 6.03 | 17.63 |
| CV(%) | 6.07 | 4.25 | 3.6 | 6.69 | 4.22 | 3.64 |
RECOVERY
The recovery of Mouse G-CSF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 89-103 | 94 |
| EDTA plasma (n=8) | 86-102 | 93 |
| Cell culture media (n=8) | 94-108 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse G-CSF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CSF2RA ELISA Kits
| CSF2RB antibody | publications with CSF2RA and CSF2RB |
| CSF2 antibody | publications with CSF2RA and CSF2 |
Pathways associated with CSF2RA ELISA Kit
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| Hematopoietic Cell Lineage Pathway | Hematopoietic Cell Lineage Pathway |
| Immune System Pathway | Immune System Pathway |
| Interleukin Receptor SHC Signaling Pathway | Interleukin Receptor SHC Signaling Pathway |
| Interleukin-2 Signaling Pathway | Interleukin-2 Signaling Pathway |
| Interleukin-3, 5 And GM-CSF Signaling Pathway | Interleukin-3, 5 And GM-CSF Signaling Pathway |
| Jak-STAT Signaling Pathway | Jak-STAT Signaling Pathway |
Diseases associated with CSF2RA ELISA Kit
| Heart Diseases | publications with CSF2RA and Heart Diseases |
| Neoplasms | publications with CSF2RA and Neoplasms |
| Cardiovascular Diseases | publications with CSF2RA and Cardiovascular Diseases |
| Skin Diseases | publications with CSF2RA and Skin Diseases |
| Brain Diseases | publications with CSF2RA and Brain Diseases |
| Nervous System Diseases | publications with CSF2RA and Nervous System Diseases |
| Heart Defects, Congenital | publications with CSF2RA and Heart Defects, Congenital |
| Necrosis | publications with CSF2RA and Necrosis |
| Immune System Diseases | publications with CSF2RA and Immune System Diseases |
| Prenatal Exposure Delayed Effects | publications with CSF2RA and Prenatal Exposure Delayed Effects |
Organs/Tissues associated with CSF2RA ELISA Kit
| Blood | publications with CSF2RA and Blood |
| Lung | publications with CSF2RA and Lung |
| Brain | publications with CSF2RA and Brain |
| Kidney | publications with CSF2RA and Kidney |
| Bone Marrow | publications with CSF2RA and Bone Marrow |
| Liver | publications with CSF2RA and Liver |
| Skin | publications with CSF2RA and Skin |